Feb 23, 2024 Assignment: Assessing and Treating Patients With Anxiety Disorders NURS 6630
Assignment: Assessing and Treating Patients With Anxiety Disorders NURS 6630
A Sample Answer For the Assignment: Assignment: Assessing and Treating Patients With Anxiety Disorders NURS 6630
Anxiety disorders are a group of illnesses with a variety of symptoms that are related to one another. One of their most common symptoms is persistent, excessive worry, particularly in non-threatening situations. Among patients, physical and emotional issues are frequent. Typically, a patient’s bodily symptoms include jitteriness and a rapid heartbeat. There are numerous varieties of anxiety disorders, including social anxiety disorder, agoraphobia, generalized anxiety disorder, and panic disorder (Bandelow et al, .2022).
In this essay, a 46-year-old Caucasian man with anxiety is the subject. He exhibits signs of an anxiety illness, including chest pain, tightness, and shortness of breath. There are no signs of a myocardial infarction, according to the results of the ER and ECK tests, which are both normal. It received a 26 rating. The patient admits that he drinks to put his mind off of some of his work-related worries. In addition, he consumes three to four beers daily.
After the data has been collected, a physical examination of the patient is necessary to confirm that the right criteria have been identified to direct the selection of drugs that will make the patient feel better. Later, the generalized anxiety disorder was identified. Treatment plans were chosen in three different approaches, all of which were based on the pharmacodynamics and pharmacokinetic processes of the patients. The ethical issues and recommendations that will impact patient care will also be discussed (Crocq 2022).
Struggling to Meet Your Deadline?
Get your assignment on Assignment: Assessing and Treating Patients With Anxiety Disorders NURS 6630 done on time by medical experts. Don’t wait – ORDER NOW!
Meet my deadline
The patient’s medical history, which shows that the patient has been exposed to various medications, is the first thing to be taken into account. The client has been adhering to a low-sodium diet in order to manage his moderate hypertension. The fact that the patient’s tonsils were taken from him when he was a child suggests that he was using an anti-inflammatory drug. The patient affirms that following the surgery, he underwent no additional adverse testing.
The patient, on the other hand, is alert and clearly oriented to place, time, and people, demonstrating that his judgment and understanding are normal. The patient denies hearing voices and having paranoid episodes. He also denies having homicidal or suicidal thoughts. Thus, quick self-medication is necessary to help the patient recover from his condition (Fung et al, .2018).
Decision one
Start Taking Lexapro 10mg OD orally
After gathering all the information regarding the medical condition, the first pharmaceutical choice that may be made is to recommend Lexapro 10 mg taken orally once daily. The decision to accept the patient to the Lexapro 10 mg treatment program was based on the patient’s final diagnosis. Selective Serotonin Reuptake Inhibitor Lexapro is used to treat post-traumatic stress, depression, panic attacks, and generalized anxiety disorder that the patient may be diagnosed with. The severity of the anxiety disorder must be determined; a score of 26 on the scale indicates that the patient’s condition has not gotten worse (Bandelow et al, .2022).
Assignment Assessing and Treating Patients With Anxiety Disorders NURS 6630
In order to assess the patient’s development over time, it is recommended to start him on the oral medication Lexapro 10 mg. Other drugs that are available include buspirone 10 mg PO bid and imipramine 25 mg PO bid. However, since the medications must be used in addition to other forms of therapy in order to be effective, they might not be in the best interests of the patients’ advancement.
Lexapro 10 mg would therefore be the ideal choice for any patient with a moderate form of generalized anxiety disorder, like the patient in question. The patient should return to the hospital for a checkup after taking the medication for one month. Making a decision was done with the intention of gauging the patient’s improved disposition and his excitement for carrying out daily chores, notably at work (Andrews et al, .2018).
Decision Point Two
Raise the dosage to 20 mg orally every day from the current level.
After four weeks, the patient must visit the clinic again to assess his development. The results show that the drug has greatly improved the patient’s symptoms. Moreover, the HAM-A score decreased from 26 to 18. The drug proved beneficial, as evidenced by the patient’s decreased concern about his employment. Given the aforementioned findings, it is obvious that the previous medication shouldn’t be stopped. Instead, for an additional four weeks, the amount can be gradually increased. Thereafter, the patient should go back to the emergency hospital for a second assessment (Yatham et al, .2018).
The decision to increase the patient’s current Lexapro dosage to 20 mg was taken to determine whether the patient might completely recover from his illness and resume his regular activities. As a result, increasing the dosage is preferable to the other two possibilities that are currently being evaluated. Second, the unit has a 40 mg Lexapro dosage increase capability. In contrast, the rise would be excessive, making it impossible for healthcare providers to bring about a progressive adjustment in the patient’s life.
For instance, the unit might keep taking Lexapro at the same dose for a further four weeks and get the same results as the first diagnosis. The doctor aims to gradually improve the patient’s condition by raising the dose; this improvement may be much greater than with the previous prescription. But, because the client has not fully recovered, he may still fail to consume the recommended amount, which could have an influence on the care plan at the designated time (Yatham et al, .2018).
Decision Point Three
Continue administering the present dose
After taking the patient medication for four weeks, the patient shows a substantial improvement and is extremely happy to return to the clinic. The patient’s anxiety level reduced to a 10 on the HAM-A scale, and the additional dosage caused his prior symptoms to fade more. This shows that the client would benefit most from taking Lexapro 10 mg daily orally to treat the generalized anxiety disorder that was identified during his initial consultation.
Although the patient has gone through several changes, there is no need to change his current medication. This option implies that the patient will fully recover from his condition if his present prescription is kept up for an additional four weeks (Bandelow et al, 2018).
It might not be beneficial to switch the client from the current prescription to another possible option, such as starting them on an enhancing drug like buspirone. At this point, it’s important to keep in mind that the client hasn’t disclosed any further symptoms he previously experienced. Instead, lowering anxiety levels even further is the aim.
Due to the larger doses that the patient will need to take, the other two medications could end up making the situation worse. In order to ensure that the anxiety level drops even further, as was the case in the third diagnostic when Lexapro dosage was increased to 20 mg taken orally daily, the current medication must be continued for an additional 4 weeks.
Nonetheless, the healthcare professional must proceed with considerable caution before allowing the patient to continue with his current prescription. The client may quit taking the medication because he thinks his illness has improved, so this warning is given. The patient might not want to take the prescribed meds on a daily basis. In order to prevent the treatment plan from being jeopardized, it is crucial to emphasize to the client the necessity to finish the dose even after he has recovered (Latas et al, .2018).
Conclusion
In conclusion, an evaluation revealed that the three drugs mentioned above are the best options for treating the client’s generalized anxiety disorder or bipolar disorder, depending on the assessment. As a result, before recommending any particular medications, mental health professionals must exercise prudence. Instead, the patient’s symptoms and the severity of the anxiety disorder as determined by the HAM-A scale should lead the therapy plan. For the first time, progressive Lexapro treatment is superior to the use of other prescription medications like imipramine and buspirone. If the patient and the healthcare provider do not interfere with the treatment plan, the Lexapro medicine will unquestionably be successful for the patient (Reddy et al, .2020).
References
Bandelow, B., Michaelis, S., & Wedekind, D. (2022). Treatment of anxiety disorders. Dialogues in clinical neuroscience. Crocq, M. A. (2022). The history of generalized anxiety disorder as a diagnostic category. Dialogues in clinical neuroscience.
Fung, A. W. T., Lee, J. S. W., Lee, A. T. C., & Lam, L. C. W. (2018). Anxiety symptoms predicted decline in episodic memory in cognitively healthy older adults: A 3‐year prospective study. International journal of geriatric psychiatry, 33(5), 748-754.
Bandelow, B., Werner, A. M., Kopp, I., Rudolf, S., Wiltink, J., & Beutel, M. E. (2022). The German Guidelines for the treatment of anxiety disorders: first revision. European archives of psychiatry and clinical neuroscience, 1-12.Andrews, G., Bell, C., Boyce, P., Gale, C., Lampe, L., Marwat, O. … & Wilkins, G. (2018). Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of panic disorder, social anxiety disorder and generalised anxiety disorder. Australian & New Zealand Journal of Psychiatry, 52(12), 1109-1172
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., … & Berk, M. (2018). Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar disorders, 20(2), 97-170.
Bandelow, B., Allgulander, C., Baldwin, D. S., Costa, D. L. D. C., Denys, D., Dilbaz, N. … & Zohar, J. (2022). World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders–Version 3. Part I: Anxiety disorders. The World Journal of Biological Psychiatry, 1-39
Latas, M., Trajković, G., Bonevski, D., Naumovska, A., Vučinić Latas, D., Bukumirić, Z., & Starčević, V. (2018). Psychiatrists’ treatment preferences for generalized anxiety disorder. Human Psychopharmacology: Clinical and Experimental, 33(1), e2643.
Reddy, Y. J., Sudhir, P. M., Manjula, M., Arumugham, S. S., & Narayanaswamy, J. C. (2020). Clinical practice guidelines for cognitive-behavioral therapies in anxiety disorders and obsessive- compulsive and related disorders. Indian journal of psychiatry, 62(Suppl 2), S230.
Common symptoms of anxiety disorders include chest pains, shortness of breath, and other physical symptoms that may be mistaken for a heart attack or other physical ailment. These manifestations often prompt patients to seek care from their primary care providers or emergency departments.
Once it is determined that there is no organic basis for these symptoms, patients are typically referred to a psychiatric mental health practitioner for anxiolytic therapy. For this Assignment, as you examine the patient case study in this week’s Learning Resources, consider how you might assess and treat patients presenting with anxiety disorders.
Generalized Anxiety Disorder: Middle-Aged White Male With Anxiety
BACKGROUND INFORMATION
The client is a 46-year-old white male who works as a welder at a local steel fabrication factory. He presents today after being referred by his PCP after a trip to the emergency room in which he felt he was having a heart attack. He stated that he felt chest tightness, shortness of breath, and feeling of impending doom. He does have some mild hypertension (which is treated with low sodium diet) and is about 15 lbs. overweight. He had his tonsils removed when he was 8 years old, but his medical history since that time has been unremarkable. Myocardial infarction was ruled out in the ER and his EKG was normal. Remainder of physical exam was WNL.
He admits that he still has problems with tightness in the chest and episodes of shortness of breath- he now terms these “anxiety attacks.” He will also report occasional feelings of impending doom, and the need to “run” or “escape” from wherever he is at.
In your office, he confesses to occasional use of ETOH to combat worries about work. He admits to consuming about 3-4 beers/night. Although he is single, he is attempting to care for aging parents in his home. He reports that the management at his place of employment is harsh, and he fears for his job. You administer the HAM-A, which yields a score of 26.
Client has never been on any type of psychotropic medication.
MENTAL STATUS EXAM
The client is alert, oriented to person, place, time, and event. He is appropriately dressed. Speech is clear, coherent, and goal-directed. Client’s self-reported mood is “bleh” and he does endorse feeling “nervous”. Affect is somewhat blunted, but does brighten several times throughout the clinical interview. Affect broad. Client denies visual or auditory hallucinations, no overt delusional or paranoid thought processes readily apparent. Judgment is grossly intact, as is insight. He denies suicidal or homicidal ideation.
Review this week’s Learning Resources, including the Medication Resources indicated for this week.Reflect on the psychopharmacologic treatments you might recommend for the assessment and treatment of patients requiring anxiolytic therapy.
The Assignment: 5 pages
Examine Case Study: A Middle-Aged Caucasian Man With Anxiety. You will be asked to make three decisions concerning the medication to prescribe to this patient. Be sure to consider factors that might impact the patient’s pharmacokinetic and pharmacodynamic processes.
At each decision point, you should evaluate all options before selecting your decision and moving throughout the exercise. Before you make your decision, make sure that you have researched each option and that you evaluate the decision that you will select. Be sure to research each option using the primary literature.
Introduction to the case (1 page)
Briefly explain and summarize the case for this Assignment. Be sure to include the specific patient factors that may impact your decision making when prescribing medication for this patient.Decision #1 (1 page)
Which decision did you select?
Why did you select this decision? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.Why did you not select the other two options provided in the exercise? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources (including the primary literature).Explain how ethical considerations may impact your treatment plan and communication with patients. Be specific and provide examples.Decision #2 (1 page)
Click here to ORDER NOW FOR AN ORIGINAL PAPER ASSIGNMENT: Assignment: Assessing and Treating Patients With Anxiety Disorders NURS 4430
Why did you select this decision? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.Why did you not select the other two options provided in the exercise? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources (including the primary literature).Explain how ethical considerations may impact your treatment plan and communication with patients. Be specific and provide examples.Decision #3 (1 page)
Why did you select this decision? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.Why did you not select the other two options provided in the exercise? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources (including the primary literature).Explain how ethical considerations may impact your treatment plan and communication with patients. Be specific and provide examples.
Conclusion (1 page)
Summarize your recommendations on the treatment options you selected for this patient. Be sure to justify your recommendations and support your response with clinically relevant and patient-specific resources, including the primary literature.Note: Support your rationale with a minimum of five academic resources. While you may use the course text to support your rationale, it will not count toward the resource requirement. You should be utilizing the primary and secondary literature.
Reminder : The College of Nursing requires that all papers submitted include a title page, introduction, summary, and references. The Sample Paper provided at the Walden Writing Center provides an example of those required elements (available at https://academicguides.waldenu.edu/writingcenter/templates/general#s-lg-box-20293632). All papers submitted must use this formatting.
By Day 7
Submit your Assignment.
Submission and Grading Information
To submit your completed Assignment for review and grading, do the following:
Please save your Assignment using the naming convention “WK6Assgn+last name+first initial.(extension)” as the name.Click the Week 6 Assignment Rubric to review the Grading Criteria for the Assignment.Click the Week 6 Assignment link. You will also be able to “View Rubric” for grading criteria from this area.Next, from the Attach File area, click on the Browse My Computer button. Find the document you saved as “WK6Assgn+last name+first initial.(extension)” and click Open.If applicable: From the Plagiarism Tools area, click the checkbox for I agree to submit my paper(s) to the Global Reference Database.Click on the Submit button to complete your submission.
Grading Criteria
To access your rubric:
Week 6 Assignment Rubric
Check Your Assignment Draft for Authenticity
To check your Assignment draft for authenticity:
Submit your Week 6 Assignment draft and review the originality report.
Submit Your Assignment by Day 7 of Week 6
To participate in this Assignment:
Week 6 Assignment
Midterm Exam
This exam will cover the following topics, which relate to psychopharmacologic approaches to treatment for patients across the life span:
Introduction to neuroscience, including concepts in neuroanatomy, neurotransmitters, and receptor theoryMedication adherencePediatric, adult, and geriatric Major Depressive Disorders (MDD)Bipolar disorderAnxiety and PTSD treatment
Photo Credit: [Vergeles_Andrey]/[iStock / Getty Images Plus]/Getty Images
Prior to starting the exam, you should review all of your materials. There is a 2.5-hour time limit to complete this 50-question exam. You may only attempt this exam once.
This exam is a test of your knowledge in preparation for your certification exam. No outside resources including books, notes, websites, or any other type of resource are to be used to complete this exam. You are expected to comply with Walden University’s Code of Conduct.
By Day 7
Submit your Midterm Exam by Day 7.
Submission Information
Submit Your Exam by Day 7
To submit your Midterm Exam:
Week 6 Midterm Exam
Week 6: Therapy for Patients With Anxiety Disorders and PTSD Treatment
I’m no longer at the mercy of my PTSD, and I would not be here today had I not had the proper diagnosis and treatment. It’s never too late to seek help.
—P.K. Philips, PTSD patient
For individuals presenting with posttraumatic stress disorder (PTSD) and other anxiety disorders, everyday life can be a constant challenge. Clients requiring anxiolytic therapy may present with anxiousness, depression, substance abuse issues, and even physical symptoms related to cardiovascular, respiratory, and gastrointestinal ailments. As a psychiatric nurse practitioner, you must be prepared to address the many needs of individuals seeking treatment for PTSD and other anxiety disorders.
This week, as you study anxiolytic therapies and PTSD treatments, you examine the assessment and treatment of patients with PTSD and other anxiety disorders. You also explore ethical and legal implications of these therapies.
Reference:
Philips, P. K. (n.d.). My story of survival: Battling PTSD. Anxiety and Depression Association of America. https://adaa.org/living-with-anxiety/personal-stories/my-story-survival-battling-ptsd
Learning Objectives
Students will:
Assess patient factors and history to develop personalized plans of anxiolytic therapy for patients
Analyze factors that influence pharmacokinetic and pharmacodynamic processes in patients requiring anxiolytic therapy
Synthesize knowledge of providing care to patients presenting with anxiolytic therapy
Analyze ethical and legal implications related to prescribing anxiolytic therapy to patients across the lifespan
Assess psychopharmacologic approaches to treatment for patients across the lifespan
Learning Resources
Required Readings (click to expand/reduce)
Bui, E., Pollack, M. H., Kinrys, G., Delong, H., Vasconcelos e Sá, D., & Simon, N. M. (2016). The pharmacotherapy of anxiety disorders. In T. A. Stern, M. Favo, T. E. Wilens, & J. F. Rosenbaum. (Eds.), Massachusetts General Hospital psychopharmacology and neurotherapeutics (pp. 61–71). Elsevier.American Psychiatric Association. (2010a). Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder. https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/acutestressdisorderptsd.pdfAmerican Psychiatric Association. (2010c). Practice guideline for the treatment of patients with panic disorder (2nd ed.). https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/panicdisorder.pdfBendek, D. M., Friedman, M. J., Zatzick, D., & Ursano, R. J. (n.d.). Guideline watch (March 2009): Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder. https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/acutestressdisorderptsd-watch.pdfCohen, J. A. (2010). Practice parameter for the assessment and treatment of children and adolescents with posttraumatic stress disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 49(4), 414–430. https://jaacap.org/action/showPdf?pii=S0890-8567%2810%2900082-1Davidson, J. (2016). Pharmacotherapy of post-traumatic stress disorder: Going beyond the guidelines. British Journal of Psychiatry, 2(6), e16–e18. 10.1192/bjpo.bp.116.003707. http://bjpo.rcpsych.org/content/2/6/e16Hamilton, M. (1959). Hamilton Anxiety Rating Scale (HAM-A). PsycTESTS. https://doi.org/10.1037/t02824-0Ostacher, M. J., & Cifu, A. S. (2019). Management of posttraumatic stress disorder. JAMA, 321(2), 200–201. https://doi.org/10.1001/jama.2018.19290Strawn, J. R., Wehry, A. M., DelBello, M. P., Rynn, M. A., & Strakowski. S. (2012). Establishing the neurobiologic basis of treatment in children and adolescents with generalized anxiety disorder. Depression and Anxiety, 29(4), 328–339. https://doi.org/10.1002/da.21913Medication Resources (click to expand/reduce)
IB
Order a similar assignment, and have writers from our team of experts write it for you, guaranteeing you an A
